The development and preliminary validation of this ultrasound patch were published in the May 26 issue of Nature Biotechnology, highlighting its innovative design and promising clinical applications. Intrauterine growth restriction poses complex challenges in obstetrics, often compelling physicians to make difficult decisions about the timing of delivery to mitigate risks such as stillbirth without exposing the neonate to the hazards of premature birth. The wearable patch addresses a crucial gap in fetal monitoring by enabling close, continuous tracking of blood flow, an essential parameter in evaluating fetal health in these scenarios.

Traditional fetal monitoring methods primarily rely on intermittent Doppler ultrasound examinations that capture fleeting images of fetal blood flow. These techniques necessitate appointment scheduling and the presence of skilled technicians, making frequent, continuous monitoring impractical. Additionally, cardiotocography, a standard method measuring fetal heart rate and uterine contractions through electronic sensors strapped to the maternal abdomen, often struggles with signal reliability due to fetal movement, limiting its utility for extended observation periods. The stress imposed on both patients and healthcare providers by the labor-intensive nature of current monitoring underscores the urgent need for a more user-friendly and reliable solution.

The ultrasound patch’s technical innovation lies in its flexible, adhesive design coupled with sophisticated imaging algorithms. Measuring approximately the size of a human palm, the patch connects to a computational system via cable, interpreting ultrasound signals into detailed blood flow data. One of the most formidable challenges the researchers overcame was the dynamic nature of the prenatal environment: the fetus frequently moves and changes position, the umbilical cord floats freely in amniotic fluid, and the maternal abdomen itself undergoes regular motion. Conventional ultrasound setups mitigate these variables through manual repositioning of the transducer; however, the wearable patch required an automated tracking solution.

To surmount this, the researchers implemented an advanced image segmentation algorithm that locks onto the placental insertion site of the umbilical cord—a relatively stable anatomical landmark despite overall fetal and maternal movement. This algorithm enables continuous real-time visualization without manual adjustment, ensuring consistent data quality regardless of maternal activity or the fetus’s orientation. Rigorous testing on simulation mannequins preceded clinical validation to confirm that the device adhered to safety standards regulated by the U.S. FDA, the American Institute of Ultrasound in Medicine, and the British Medical Ultrasound Society, particularly concerning acoustic and mechanical energy emissions to ensure fetal safety.

Clinical validation involved a cohort of 62 pregnant individuals, spanning various stages and conditions, in whom the patch’s data were directly compared to those obtained via conventional Doppler ultrasound machines. Statistical analysis revealed equivalence in performance, demonstrating the patch’s capacity to reliably capture blood flow velocity and volume in the two umbilical arteries and the umbilical vein, as well as flow within a major fetal artery. Notably, the patch’s imaging capabilities extend beyond vascular assessment, allowing measurement of critical fetal anatomical parameters such as head circumference, abdominal circumference, and femur length, which are instrumental in estimating fetal weight and diagnosing growth anomalies.

An extraordinary outcome of the clinical trial was the early detection of a severe vascular abnormality in a participant at 28 weeks’ gestation. Initial fetal heart rate assessments appeared normal; however, the ultrasound patch revealed abnormal fluctuations in umbilical cord blood flow. Confirmatory follow-up evaluations verified significant placental dysfunction, prompting intensive monitoring and ultimately enabling timely cesarean delivery. The neonate, though initially requiring intensive care, demonstrated favorable progress, underscoring the patch’s potential lifesaving impact through early risk identification.

Future directions for this technology include the development of a wireless iteration of the patch to facilitate outpatient monitoring, thereby extending its utility beyond the hospital setting. Further research will explore its application across a broader spectrum of pregnancy complications characterized by compromised blood flow, such as congenital heart disease and chronic maternal hypertension. These expansions could revolutionize prenatal care by providing clinicians with a continuous stream of meaningful, actionable data, improving decision-making during critical junctures in complicated pregnancies.

The collaboration between clinical experts, biomedical engineers, and computer scientists has yielded a device that could markedly alleviate the logistical and technical barriers currently impeding optimal fetal monitoring. Dr. Jane Chueh, a high-risk obstetrician collaborating on this project, emphasizes the transformative potential of having immediate, continuous information available without the burden of repeated technician input or complex setups. This level of monitoring granularity not only enhances patient care but may also reduce the anxiety and physical strain for expectant mothers, especially those requiring hospitalization.

Broadly, the wearable ultrasound patch exemplifies how evolutionary advances in wearable technology, artificial intelligence, and medical imaging can converge to address longstanding challenges in prenatal medicine. By targeting the placental insertion of the umbilical cord as a stable anchor point for imaging, the device innovatively tackles the inherent problem of movement artifacts—a significant limitation in traditional ultrasound diagnostics. From a physiological standpoint, persistent monitoring of umbilical and fetal artery flow is invaluable in early detection of fetal distress, potentially preempting adverse outcomes and optimizing delivery timing.

The project’s financial backing from the National Institutes of Health, alongside support from Wellcome Leap and UC San Diego’s Accelerating Innovation to Market program, has been integral to the multidisciplinary effort needed to advance this technology from concept to clinical reality. Continued funding will be essential for larger-scale trials, refinement of wireless capabilities, and integration with existing prenatal monitoring infrastructure.

Ultimately, this ultrasound patch holds the promise not only of redefining fetal monitoring standards in high-risk obstetrics but also of inspiring parallel innovations in remote maternal-fetal health surveillance. Its adoption could usher in a new era where pregnancy care is more personalized, proactive, and accessible, thereby improving outcomes for mothers and their babies worldwide.

Subject of Research: People
Article Title: Fetal monitoring for high-risk pregnancies using a wearable ultrasound patch
News Publication Date: 26-May-2026
Web References: https://www.nature.com/articles/s41587-026-03140-1
References: 10.1038/s41587-026-03140-1
Keywords: Pregnancy, Pregnancy complications, Fetal monitoring, Wearable ultrasound, Intrauterine growth restriction, Fetal blood flow, Obstetrics, High-risk pregnancy, Medical devices, Prenatal care

Conventional fetal ultrasonography necessitates highly trained operators to manually acquire anatomical images and Doppler flow measurements at specific instances during pregnancy. These “snapshot” assessments, although clinically valuable, are constrained by their intermittent nature and dependency on healthcare facility access. The UPatch addresses these challenges by integrating sophisticated ultrasound transducer arrays into a flexible, skin-conforming patch that can be comfortably worn on the maternal abdomen. This design allows for ongoing acquisition of key fetal parameters, including detailed anatomical structures and blood flow velocities, without active clinician involvement.

A pivotal breakthrough underpinning the UPatch’s functionality is its embedded real-time image segmentation system powered by advanced machine learning algorithms. This enables autonomous identification and tracking of target fetal and maternal blood vessels throughout the monitoring period. As a result, the device can acquire continuous Doppler blood flow spectra, maintaining data integrity even amidst fetal and maternal movements, which traditionally hindered reliable measurement acquisition. The synergy between hardware innovation and intelligent software thus facilitates stable, high-fidelity fetal monitoring outside clinical environments.

Validation studies encompassing 62 pregnancies have demonstrated that the UPatch yields anatomical and hemodynamic measurements in very close agreement with those obtained by conventional handheld clinical ultrasound devices. This concordance underscores the patch’s potential to match clinical-grade imaging standards while offering the added benefits of continuous monitoring. Importantly, the autonomous operation reduces the need for sonographer intervention, potentially democratizing access to essential prenatal diagnostics, especially in resource-limited settings.

Insights gleaned from continuous monitoring data of 52 pregnant women reveal compelling correlations with diverse stratified perinatal conditions. The UPatch successfully differentiated between normal pregnancies and those complicated by factors such as small for gestational age (SGA), large for gestational age (LGA), gestational diabetes, preeclampsia, and gestational hypertension. These findings suggest the device’s capability to provide early warnings of fetal compromise, offering clinicians a dynamic overview of placental function and fetal well-being that was previously unattainable through sporadic clinical ultrasounds.

The ability to track fetal hemodynamic responses in real time is especially consequential in managing high-risk pregnancies where fetal growth abnormalities or hypertensive disorders could induce acute complications. Continuous Doppler assessment of critical vessels such as the umbilical artery or middle cerebral artery provides nuanced hemodynamic profiles, enabling clinicians to detect subtle deviations from normative patterns. This proactive surveillance could inform timely interventions, ultimately improving perinatal outcomes.

A further stride towards real-world applicability lies in the UPatch’s comfort and form factor. Its flexible design ensures adherence to the maternal abdomen without compromising mobility or daily activities. Unlike bulkier ultrasound equipment, this patch-based system offers unprecedented patient convenience, facilitating long-term monitoring at home, thus reducing hospital visits and healthcare system burdens. Such attributes render it ideally suited for continuous outpatient fetal surveillance.

Anticipating future integration, the research team envisions coupling the UPatch with miniaturized electronic circuits and fully wireless operation modules. This would enable seamless data transmission to cloud platforms for remote analysis by healthcare providers, empowering prenatal telemedicine paradigms. The miniaturization roadmap also anticipates enhanced battery life and user-friendly interfaces that could further ease adoption by expectant mothers and clinicians alike.

Technically, the device employs advanced piezoelectric materials arranged in dense transducer arrays capable of both B-mode anatomical imaging and pulsed-wave Doppler flow measurements. The flexible substrate conforms intimately to the skin surface, minimizing acoustic impedance mismatches and motion artifacts. These engineering innovations are complemented by embedded signal processing units capable of handling high-throughput ultrasound data streams in real time.

Moreover, sophisticated deep learning frameworks embedded within the patch facilitate segmentation and vessel tracking without operator input. The algorithms were trained on diverse ultrasound datasets to enhance robustness across variable fetal positions, gestational ages, and maternal body habitus. This autonomous image analysis pipeline distinguishes vessels of interest while compensating for maternal respiratory and fetal movements, critical for consistent spectral Doppler acquisition.

From a clinical workflow perspective, the UPatch holds transformative potentials. By offering continuous longitudinal datasets, clinicians can access detailed growth trajectories and vascular flow patterns over days or weeks. This contrasts starkly with current discrete evaluations, where critical temporal dynamics might be missed. The enhanced temporal resolution will enrich diagnostic accuracy and may guide personalized management strategies tailored to the evolving fetal condition.

The UPatch’s data-rich outputs also present an opportunity for integration with other prenatal biometrics and electronic health records, enabling multifactorial risk stratification. Machine learning models synthesizing diverse clinical inputs alongside continuous ultrasound monitoring could generate predictive analytics, assisting early detection of fetal compromise and informing obstetric decision-making. This heralds a new paradigm of data-driven personalized prenatal care.

Importantly, this technology could address global disparities in prenatal healthcare, where limited access to skilled sonographers and diagnostic tools often results in delayed or inadequate fetal assessment. The ease of use and autonomous operation of the UPatch could enhance monitoring accessibility in underserved settings, potentially reducing adverse outcomes associated with undetected fetal distress.

While promising, the UPatch still requires further optimization, especially in expanding the wireless capabilities and integrating the full electronic system into a compact wearable unit. Clinical trials involving larger cohorts and diverse populations will be essential to robustly evaluate its efficacy across varying clinical conditions and gestational stages. Regulatory approvals and standardization will also be integral to its widescale adoption.

Nevertheless, the emergence of the UPatch marks a significant milestone in prenatal diagnostics, underscoring the synergy between material innovation, machine learning, and clinical medicine. By enabling continuous, autonomous fetal monitoring through a wearable platform, this technology opens new frontiers in maternal-fetal care, with the potential to improve outcomes for countless pregnancies worldwide. As development continues, the vision of seamless, at-home fetal surveillance is steadily turning into reality.

In conclusion, the wearable ultrasound patch not only redefines fetal monitoring by allowing uninterrupted, hands-free acquisition of critical biometric data but also establishes a new standard for accessible, data-driven prenatal care. By bridging gaps in traditional ultrasound limitations, it equips clinicians with richer insights and expectant mothers with enhanced peace of mind. The future of fetal health monitoring is on the horizon, glowing with possibility and powered by innovation.

Subject of Research: Fetal monitoring and prenatal care using wearable ultrasound technology.

Article Title: Fetal monitoring for high-risk pregnancies using a wearable ultrasound patch.

Article References:
Park, G., Bian, Y., Huang, H. et al. Fetal monitoring for high-risk pregnancies using a wearable ultrasound patch. Nat Biotechnol (2026). https://doi.org/10.1038/s41587-026-03140-1

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41587-026-03140-1

The impetus behind this innovation stems from the challenges inherent in fetal monitoring. Fetuses are constantly moving, and their umbilical cords shift position unpredictably, complicating consistent measurement with existing technologies. The UC San Diego team overcame these barriers by integrating advanced autonomous tracking algorithms within the wearable patch. These algorithms precisely identify and follow the umbilical cord’s position amid fetal and maternal motion, enabling reliable and uninterrupted measurements of critical parameters such as blood flow velocity and cardiac signals. This autonomy is crucial for maintaining data integrity during hours-long monitoring sessions.

During rigorous clinical trials conducted at prominent medical centers including UC San Diego Health’s Jacobs Medical Center and the University of Oxford’s John Radcliffe Hospital, the patch demonstrated remarkable fidelity. It generated continuous readings closely mirroring those obtained from gold-standard handheld ultrasound devices. Notably, the system monitored 62 pregnancies featuring a spectrum of conditions, ranging from normal development to high-risk scenarios characterized by gestational diabetes, pre-eclampsia, and fetal growth abnormalities. This robust dataset validates the device’s versatility and reliability across a diverse patient population.

One of the most compelling clinical outcomes emerged when the patch detected prolonged abnormal fetal signals indicative of distress. This early warning precipitated a timely medical intervention leading to a preterm Cesarean delivery at 29 weeks. Physicians credit the continuous monitoring capability for potentially saving the infant’s life by enabling earlier detection than conventional episodic ultrasounds permit. The case highlights the immense potential of wearable ultrasound technology to shift prenatal care paradigms, facilitating proactive management of complications that were previously challenging to identify in a timely manner.

The core technology enabling this breakthrough is built on a decade of pioneering research led by Professor Sheng Xu within UC San Diego’s Department of Chemical and Nano Engineering. His laboratory has been at the forefront of developing wearable ultrasound devices with broad healthcare applications, including noninvasive blood pressure monitoring and mobile cardiac imaging. By leveraging flexible electronics and miniaturized transducers, this ultrasound patch melds comfort with unprecedented functional capability. The current iteration integrates bio-compatible materials that conform intimately to the skin, ensuring consistent acoustic coupling necessary for clear imaging.

Beyond clinical efficacy, the wearable patch holds promise for expanding access to quality prenatal care globally, particularly in low-resource settings where skilled sonographers and continuous monitoring equipment are scarce. The design enables simplified use without expert operators, potentially democratizing fetal health monitoring and reducing disparities in maternal-fetal health outcomes worldwide. Additionally, the team’s future objective includes developing a fully wireless, compact electronic system to further enhance the patch’s portability and user-friendliness.

Technical sophistication underlies the patch’s ability to capture complex hemodynamic parameters. It utilizes high-frequency ultrasound transducers arrayed in a flexible matrix, optimized to penetrate maternal tissue and visualize both the fetus and umbilical cord structures. The embedded machine-learning algorithms analyze returned signals to differentiate subtle variations in blood flow and structural motion, effectively filtering out artifacts from maternal movement. This real-time signal processing is essential for maintaining measurement precision during the natural movements and physiological changes encountered during pregnancy.

The research team also underscores the importance of autonomous operation in clinical contexts. Unlike conventional ultrasounds that necessitate manually repositioning probes to maintain image clarity, the wearable system’s software dynamically adjusts scanning parameters and focal zones based on ongoing feedback from tracking algorithms. This closed-loop control ensures continuous acquisition of diagnostically relevant data without disrupting maternal comfort or requiring frequent clinical visits. Such autonomy marks a significant evolution in non-invasive fetal diagnostics.

In terms of clinical adoption, the wearable ultrasound patch could integrate seamlessly into existing prenatal care frameworks. Physicians could remotely monitor patients through digital interfaces connected to the patch’s data stream, enabling timely interventions guided by continuous physiological insights. The technology aligns with emerging trends toward telemedicine and home-based health monitoring, especially critical during periods when in-person visits may be limited, such as during global health crises. This proactive approach could significantly enhance outcomes for mothers and their babies worldwide.

The research was disseminated in a recent publication in the prestigious journal Nature Biotechnology, underscoring its scientific rigor and potential impact. Funding support came from prominent agencies including the Wellcome Leap initiative and the National Institutes of Health, reflecting the project’s high priority in the biomedical research community. The cross-institutional collaboration—with contributions from UC San Diego and the University of Oxford—further emphasizes the global commitment to advancing maternal-fetal health technologies.

Looking ahead, the engineering team is focused on miniaturizing the electronics and incorporating wireless power and data transmission capabilities. These innovations will eliminate the need for tethered connections, enhancing maternal mobility and enabling long-term outpatient monitoring. Such advancements will facilitate integration with smartphone applications and healthcare provider systems, creating a comprehensive ecosystem for prenatal surveillance. This trajectory aligns with broader trends in wearable health technologies aiming to deliver continuous, real-time diagnostics beyond traditional clinical environments.

In summary, this wearable ultrasound patch signifies a paradigm shift in prenatal care. Marrying cutting-edge materials science, flexible electronics, and autonomous algorithms, it delivers continuous, high-fidelity fetal monitoring that was previously unattainable. The ability to detect complications earlier and operate without specialized operators opens new horizons in maternal and neonatal health. As development proceeds toward wireless, user-friendly designs, this technology promises to become an indispensable tool in safeguarding the next generation’s well-being from the earliest stages of life.

Subject of Research: Continuous fetal monitoring during pregnancy using wearable ultrasound technology
Article Title: Fetal monitoring for high-risk pregnancies using a wearable ultrasound patch
News Publication Date: 26-May-2026
Web References: 10.1038/s41587-026-03140-1
Image Credits: Geonho (Tom) Park

Keywords

Wearable ultrasound, prenatal monitoring, fetal health, umbilical cord tracking, high-risk pregnancy, continuous fetal monitoring, flexible electronics, autonomous algorithms, maternal-fetal diagnostics, non-invasive ultrasound patch, machine learning, biomedical innovation